Prakash Raman
Director · Black Diamond Therapeutics, Inc.
Individual
- 2024
- Sep 21, 2026
- 8
Other insiders active in the same sector
No other insider has filed at Prakash Raman's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- J.H. Whitney Equity Partners VII, LLC - $319.15M in AVAH purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $317.75M in CELC purchases and sales in the last 12 months
- Fairmount Funds Management LLC - $300.01M in ORKA purchases and sales in the last 12 months
- A/S Genmab - $234.86M in MRUS purchases and sales in the last 12 months
- Weiss Asset Management LP - $233.35M in AVDL purchases and sales in the last 12 months
- James Edgemond - $201.52M in UTHR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Prakash Raman?
Prakash Raman is a corporate insider, tracked as Director of Black Diamond Therapeutics, Inc. (BDTX). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Prakash Raman submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
